August 12th 2025
The target action date for the application is December 11, 2025.
Predictive model quantifies risk of antibiotic resistance in uUTI
May 24th 2024The predictive models identified the number of previous UTI episodes, prior β-lactam nonsusceptibility, prior fluoroquinolone treatment, Census Bureau region (particularly in the South), and race as key predictors of having a non-susceptible isolate to 3 or more antibiotic classes.
Future research directions following study of UTI rates in transgender women post-vaginoplasty
May 14th 2024"We did discuss a couple of future research ideas, a number of which would have been controlling for those potential factors we thought could contribute to the increased UTI risk that we were not able to control for in the study like loss of commensal bacteria or anything of that nature," says David Gilbert.
Study identifies method to reduce extended-spectrum antibiotic use for UTI
May 1st 2024"Results from these trials show that giving physicians an alert informing them of their patient’s actual risk for antibiotic resistance can help them choose the best antibiotic and reduce extended-spectrum antibiotic use,” says Shruti Gohil, MD, MPH.
Dr. Burton discusses Aquablation outcomes in men with urinary retention
July 19th 2023"What we found is that those with acute urinary retention took longer to ultimately pass their trial without a catheter, meaning that they were voiding without the use of any catheterization," says Claire S. Burton, MD.
Study points to heterogeneity of urologic chronic pelvic pain syndrome
April 11th 2023“I would say that these conditions are highly heterogeneous, and we've identified a number of factors that relate to different ways that the disease progresses and different ways that patients feel about the progression of their disease,” says Alisa J. Stephens-Shields, PhD.
How MAPP results can inform future studies on urologic chronic pelvic pain syndrome
March 30th 2023“We would like to use all of what we've learned in the MAPP to move back into the space of clinical trials and trying to identify effective therapies for this condition,” says Alisa J. Stephen-Shields, PhD.